Abstract
Coronavirus disease 2019 (COVID-19) is a respiratory disease caused by a severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In an effort to combat the pandemic caused by COVID-19 disease, researchers have identified several traditional medicinal plants (TMPs) as potential adjuvant, prophylactic, and treatment for COVID-19. TMPs reported in this paper were identified based on the findings of molecular docking research and the documented traditional use of these plants for COVID-19-related symptoms, such as fever, coughing, headaches, and tiredness. Secondary metabolites with antiviral, anti-inflammatory, and immunomodulatory activity against various SARS-CoV-2 proteases were also identified from the list of South African medicinal plants. This review discusses secondary metabolites of TMPs with pharmacological benefits, which contribute to the management of COVID-19, and these include Acacia Senegal, Artemisia afra, Aspalathus linearis, Clerodendrum splendens, Dioscorea batatas decne, Echinacea purpurea, Hypoxis hemerocallidea, Xysmalobium undulatum, Tinospora crispa, Sutherladia frutescens, and Zingiber officinale.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have